Drug profile · INN
rabeprazole
APO-RABEPRAZOLE
rabeprazole (APO-RABEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 1
Pipeline programs 5
News articles 0
Drug details — rabeprazole
- Class
- —
- Route
- —
- Patents
- 1
- Programs
- 5
- Data quality
- 0.81
Quick answer
rabeprazole (APO-RABEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
Key facts
INN rabeprazole
Brand APO-RABEPRAZOLE
Mechanism Potassium-transporting ATPase inhibitor
Originator Alphapharm Pty Ltd
Mechanism of action
Potassium-transporting ATPase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
Frequently asked questions
What is rabeprazole?
rabeprazole (APO-RABEPRAZOLE) is a potassium-transporting atpase inhibitor. Associated with Alphapharm Pty Ltd.
What is the brand name for rabeprazole?
APO-RABEPRAZOLE is a marketed brand name for rabeprazole. Check FDA Drugs@FDA for the current US label holder and prescribing information.